Level D· Scientific groundwork from lab and animal studiesNarrative ReviewPubMed

Fat Grafting for Facial Rejuvenation through Injectable Tissue Replacement and Regeneration: A Differential, Standardized, Anatomic Approach.

Cohen SR., Womack H., Ghanem A.

Narrative Review on Skin Aging, Facial Rejuvenation, published in Clin Plast Surg (2019) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Clin Plast Surg (2019)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
31739895
DOI
10.1016/j.cps.2019.08.005
Citations
21

Abstract (original English)

Injectable tissue replacement and regeneration (ITR 2 ) is a standardized fat grafting technique, which anatomically addresses losses of facial volume, laxity, and sun damage of the skin resulting from the natural processes of aging. Based on the structural differences of fat existing in the deeper versus the superficial fat compartments of the face, while accounting for skeletal losses and skin aging, ITR 2 utilizes 3 sizes of fat grafts-millifat (parcel size 2.0-2.5 mm), microfat (1.0 mm), and nanofat (<500 μm)-to replicate characteristics of fat cells lost with facial decay and provide increased blood supply and improvements in aging skin.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AdipocytesAdipose TissueFaceHumansPlastic Surgery ProceduresRegenerationRejuvenationSkin Aging

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research